Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology

por Hess, Lisa M, Brnabic, Alan, Mason, Oksana, Lee, Pablo, Barker, Scott
Publicado 2019

Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community Practices

por Nadler, Eric, Aguilar, Kathleen, Wentworth, Chuck, Boyd, Marley, Amirian, E. Susan, Barker, Scott, French, Pearl, Wilson, Thomas, Hess, Lisa M.
Publicado 2020

Incidence and Management of Olaratumab Infusion-Related Reactions

por Van Tine, Brian A., Govindarajan, Rangaswamy, Attia, Steven, Somaiah, Neeta, Barker, Scott S., Shahir, Ashwin, Barrett, Emily, Lee, Pablo, Wacheck, Volker, Ramage, Samuel C., Tap, William D.
Publicado 2019

Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

por Drilon, Alexander, Subbiah, Vivek, Gautschi, Oliver, Tomasini, Pascale, de Braud, Filippo, Solomon, Benjamin J., Shao-Weng Tan, Daniel, Alonso, Guzmán, Wolf, Jürgen, Park, Keunchil, Goto, Koichi, Soldatenkova, Victoria, Szymczak, Sylwia, Barker, Scott S., Puri, Tarun, Bence Lin, Aimee, Loong, Herbert, Besse, Benjamin
Publicado 2023